Tenax Therapeutics Stock Target Price and Analyst Consensus
| TENX Stock | USD 6.41 0.05 0.79% |
The current analyst and expert consensus on Tenax Therapeutics is Strong Buy, with 3 strong buy opinions. The current projected Tenax Therapeutics target price consensus is 16.30 with 4 analyst opinions. Check out Macroaxis Advice on Tenax Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy Tenax Stock please use our How to Invest in Tenax Therapeutics guide.The most common way Tenax Therapeutics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Tenax Therapeutics executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Tenax Therapeutics. We encourage you to use your own analysis of Tenax Therapeutics to validate this buy or sell advice. Tenax Therapeutics buy-or-sell recommendation module provides average expert sentiment on the projected Tenax Therapeutics target price to derive its highest and lowest estimates based on projected price volatility of 4.121.
Lowest Forecast 14.83 | Highest Forecast 18.09 | Target Price 16.3 |
Tenax |
It's important to approach Tenax Therapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Tenax Therapeutics Target Price Consensus
Tenax target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Tenax Therapeutics' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 4 | Strong Buy |
Most Tenax analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Tenax stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Tenax Therapeutics, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationTenax Therapeutics Target Price Projection
Tenax Therapeutics' current and average target prices are 6.41 and 16.30, respectively. The current price of Tenax Therapeutics is the price at which Tenax Therapeutics is currently trading. On the other hand, Tenax Therapeutics' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Tenax Therapeutics Market Quote on 15th of March 2025
Target Price
Analyst Consensus On Tenax Therapeutics Target Price
Tenax Therapeutics Analyst Ratings
Tenax Therapeutics' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Tenax Therapeutics stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Tenax Therapeutics' financials, market performance, and future outlook by experienced professionals. Tenax Therapeutics' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Tenax Therapeutics price targets
Tenax Therapeutics' stock target price is an estimate of its future price, usually made by analysts. Using Tenax Therapeutics' target price to determine if it is a suitable investment can be done through the following steps:- Look at Tenax Therapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Tenax Therapeutics' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Tenax Therapeutics Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Tenax Therapeutics is a key component of Tenax Therapeutics valuation and have some predictive power on the future returns of a Tenax Therapeutics.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Macroaxis Index Invested few shares | |
 | Momentum Invested few shares | |
 | Macroaxis Picks Invested few shares | |
 | Adviser Favorites Invested few shares | |
 | Warren Buffett Holdings Invested few shares | |
 | Hedge Favorites Invested over 60 shares | |
 | Social Domain Invested few shares | |
 | SRI Sustainable Growth Invested over 40 shares | |
 | Apparel Invested over 40 shares | |
 | Casinos Sold over 90 shares | |
 | Utilities Invested over 90 shares | |
Additional Tools for Tenax Stock Analysis
When running Tenax Therapeutics' price analysis, check to measure Tenax Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tenax Therapeutics is operating at the current time. Most of Tenax Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tenax Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tenax Therapeutics' price. Additionally, you may evaluate how the addition of Tenax Therapeutics to your portfolios can decrease your overall portfolio volatility.